---
$id: https://graph.org.ai/products/commodity/51263501
$type: Product
source: UNSPSC
code: "51263501"
title: "Hexoprenaline"
class: "51263500"
classTitle: "Adrenergic blocking agent phenethylamines and quinolines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hexoprenaline

**UNSPSC Code**: 51263501
**Class**: [Adrenergic blocking agent phenethylamines and quinolines](Adrenergic blocking agent phenethylamines and quinolines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an adrenergic beta-2 receptor agonist, bronchodilator agent, and tocolytic agent with the molecular formula C22H32N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G9L6B3W684, chemically known as 1,12-bis(3,4-dihydroxyphenyl)-3,10-diaza-1,12-dodecandiol but generally known as hexoprenaline, which bears US NIH Compound Identifier 3609. European Medicines Agency schedules Hexoprenaline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08041MIG. World Health Organization schedules hexoprenaline in its Anatomical Therapeutic Chemical (ATC) Classification. HEXOPRENALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule hexoprenaline under HS 29225000 and SITC 51467. As of Q4 2014, HEXOPRENALINE remains the US FDA Preferred Term for this commodity. SMILES: OC(CNCCCCCCNCC(O)C1CC(O)C(O)CC1)C1CC(O)C(O)CC1.

